ASX:MYX - Mayne Pharma Group Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started A$0.58 0.00 (0.00 %) (As of 05/19/2019 04:00 PM ET)Previous CloseA$0.59Today's RangeA$0.58 - A$0.5952-Week RangeA$0.63 - A$1.43Volume3.06 million shsAverage Volume6.32 million shsMarket Capitalization$926.02 millionP/E Ratio18.87Dividend YieldN/ABetaN/A ProfileChartInsider TradesHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products worldwide. It operates through four segments: Generic Products, Specialty Brands, Metrics Contract Services, and Mayne Pharma International. The company also offers oral drug delivery systems; and contract development and manufacturing services to third-party customers. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited is based in Salisbury South, Australia. Receive MYX News and Ratings via Email Sign-up to receive the latest news and ratings for MYX and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange ASX Industry Drug Manufacturers - Major Sub-IndustryN/A SectorMedical Current SymbolASX:MYX Previous Symbol CUSIPN/A CIKN/A Webwww.maynepharma.com Phone+61-8-82092666Debt Debt-to-Equity Ratio30.42 Current Ratio1.99 Quick Ratio1.52Price-To-Earnings Trailing P/E Ratio18.87 Forward P/E Ratio11.70 P/E GrowthN/A Sales & Book Value Annual Sales$561.43 million Price / Sales1.65 Cash FlowA$0.06 per share Price / Cash Flow10.63 Book ValueA$0.82 per share Price / Book0.72Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees780 Outstanding Shares1,582,940,032Market Cap$926.02 million Next Earnings DateN/A OptionableNot Optionable Mayne Pharma Group (ASX:MYX) Frequently Asked Questions What is Mayne Pharma Group's stock symbol? Mayne Pharma Group trades on the ASX under the ticker symbol "MYX." Has Mayne Pharma Group been receiving favorable news coverage? News articles about MYX stock have been trending somewhat positive recently, according to InfoTrie Sentiment. InfoTrie identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Mayne Pharma Group earned a news impact score of 1.9 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 4.0 out of 10, indicating that recent media coverage is somewhat unlikely to have an effect on the stock's share price in the next several days. Who are some of Mayne Pharma Group's key competitors? Some companies that are related to Mayne Pharma Group include Dechra Pharmaceuticals (DPH), Hutchison China MediTech (HCM), Vectura Group (VEC), Medical Developments International (MVP), Eco Animal Health Group (EAH), BEXIMCO PHARMAC/S GDR REGS (BXP), Opthea (OPT), Trilogy International Partners (TRL), Pharmaxis (PXS), Allergy Therapeutics (AGY), Vita Life Sciences (VLS), Futura Medical (FUM), Cathay International (CTI), Recce Pharmaceuticals (RCE) and Patrys (PAB). What other stocks do shareholders of Mayne Pharma Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other Mayne Pharma Group investors own include Turquoise Hill Resources (TRQ), Aurora Cannabis (ACB), SUNDANCE ENERGY/S (SNDE), Green Organic Dutchman (TGODF), OrganiGram (OGRMF), Cronos Group (CRON), Westpac Banking (WBC), Telstra (TLS), Perseus Mining (PRU) and Karoon Energy (KAR). Who are Mayne Pharma Group's key executives? Mayne Pharma Group's management team includes the folowing people: Mr. Scott Anthony Richards, MD, CEO & Exec. Director (Age 55)Mr. Nick Freeman BCom, CA, Group CFO & Company Sec.Mr. Stefan J. Cross, Pres of International Operations (Age 46)Dr. Ilana Stancovski, Chief Scientific Officer & Head of European Market Devel.Ms. Lisa Pendlebury, VP of Investor Relations & Communications What is Mayne Pharma Group's stock price today? One share of MYX stock can currently be purchased for approximately A$0.59. How big of a company is Mayne Pharma Group? Mayne Pharma Group has a market capitalization of $926.02 million and generates $561.43 million in revenue each year. Mayne Pharma Group employs 780 workers across the globe. What is Mayne Pharma Group's official website? The official website for Mayne Pharma Group is http://www.maynepharma.com/. How can I contact Mayne Pharma Group? Mayne Pharma Group's mailing address is 1538 Main North Rd, ADELAIDE, SA 5106, Australia. The company can be reached via phone at +61-8-82092666. MarketBeat Community Rating for Mayne Pharma Group (ASX MYX)Community Ranking: 2.7 out of 5 ( )Outperform Votes: 50 (Vote Outperform)Underperform Votes: 44 (Vote Underperform)Total Votes: 94MarketBeat's community ratings are surveys of what our community members think about Mayne Pharma Group and other stocks. Vote "Outperform" if you believe MYX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MYX will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/19/2019 by MarketBeat.com StaffFeatured Article: Fibonacci Channel Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.